Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma

Progress in Retinal and Eye Research - Tập 89 - Trang 101030 - 2022
Peiwei Chai1,2, Ruobing Jia1,2, Yongyun Li1,2, Chuandi Zhou1,2, Xiang Gu1,2, Ludi Yang1,2, Hanhan Shi1,2, Hao Tian1,2, Huimin Lin1,2, Jie Yu1,2, Ai Zhuang1,2, Shengfang Ge1,2, Renbing Jia1,2, Xianqun Fan1,2
1Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, 200025, PR China
2Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, 200025, PR China

Tài liệu tham khảo

Achberger, 2014, Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease, Mol. Immunol., 58, 182, 10.1016/j.molimm.2013.11.018 Adams, 1975, Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA, Nature, 255, 28, 10.1038/255028a0 Afshar, 2020, Next-generation sequencing of retinoblastoma identifies pathogenic alterations beyond RB1 inactivation that correlate with aggressive histopathologic features, Ophthalmology, 127, 804, 10.1016/j.ophtha.2019.12.005 Alarcón, 2015, HNRNPA2B1 is a mediator of m6A-dependent nuclear RNA processing events, Cell, 162, 1299, 10.1016/j.cell.2015.08.011 Albert, 1988, Recent studies of the retinoblastoma gene. What it means to the ophthalmologist, Arch. Ophthalmol., 106, 181, 10.1001/archopht.1988.01060130191021 Amaro, 2020, Potential onco-suppressive role of miR122 and miR144 in uveal melanoma through ADAM10 and C-met inhibition, Cancers, 12, 10.3390/cancers12061468 Ambrosini, 2019, Inhibition of NF-kappaB-Dependent signaling enhances sensitivity and overcomes resistance to BET inhibition in uveal melanoma, Cancer Res., 79, 2415, 10.1158/0008-5472.CAN-18-3177 An, 2015, miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2, Cell Death Dis., 6, 10.1038/cddis.2015.123 Anastasiadou, 2018, Non-coding RNA networks in cancer, Nat. Rev. Cancer, 18, 5, 10.1038/nrc.2017.99 Aughton, 2020, MicroRNAs and uveal melanoma: understanding the diverse role of these small molecular regulators, Int. J. Mol. Sci., 21, 10.3390/ijms21165648 Babar, 2012, Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma, Proc. Natl. Acad. Sci. Unit. States Am., 109, E1695, 10.1073/pnas.1201516109 Bailey, 2018, Kinome-wide transcriptional profiling of uveal melanoma reveals new vulnerabilities to targeted therapeutics, Pigment Cell. Melanoma Res., 31, 253, 10.1111/pcmr.12650 Bande, 2020, The role of non-coding RNAs in uveal melanoma, Cancers, 12, 10.3390/cancers12102944 Barbagallo, 2020, LncRNA LINC00518 acts as an oncogene in uveal melanoma by regulating an RNA-based network, Cancers, 12, 10.3390/cancers12123867 Barisione, 2015, Potential role of soluble c-met as a new candidate biomarker of metastatic uveal melanoma, JAMA Ophthalmol., 133, 1013, 10.1001/jamaophthalmol.2015.1766 Bartel, 2018, Metazoan MicroRNAs, Cell, 173, 20, 10.1016/j.cell.2018.03.006 Bastonini, 2014, Chromatin barcodes as biomarkers for melanoma, Pigment Cell Melanoma Res., 27, 788, 10.1111/pcmr.12258 Bates, 2020, Epigenetic therapies for cancer, N. Engl. J. Med., 383, 650, 10.1056/NEJMra1805035 Baylin, 2011, A decade of exploring the cancer epigenome—biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130 Baylin, 2011, A decade of exploring the cancer epigenome - biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130 Baylin, 2011, A decade of exploring the cancer epigenome - biological and translational implications, Nat. Rev. Cancer, 11, 726, 10.1038/nrc3130 Bejerano, 2004, Ultraconserved elements in the human genome, Science, 304, 1321, 10.1126/science.1098119 Bennett, 2018, Targeting epigenetics in cancer, Annu. Rev. Pharmacol. Toxicol., 58, 187, 10.1146/annurev-pharmtox-010716-105106 Benson, 2015, Carboplatin with decitabine therapy, in recurrent platinum resistant ovarian cancer, alters circulating miRNAs concentrations: a pilot study, PLoS One, 10, 10.1371/journal.pone.0141279 Berdasco, 2017, DNA methylomes reveal biological networks involved in human eye development, functions and associated disorders, Sci. Rep., 7, 10.1038/s41598-017-12084-1 Berry, 2017, Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma, JAMA Ophthalmol., 135, 1221, 10.1001/jamaophthalmol.2017.4097 Beta, 2014, EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression, PLoS One, 9, 10.1371/journal.pone.0114800 Beta, 2013, Identification and insilico analysis of retinoblastoma serum microRNA profile and gene targets towards prediction of novel serum biomarkers, Bioinf. Biol. Insights, 7, 21, 10.4137/BBI.S10501 Bewersdorf, 2019, Epigenetic therapy combinations in acute myeloid leukemia: what are the options?, Ther. Adv. Hematol., 10, 10.1177/2040620718816698 Blanco, 2016, Stem cell function and stress response are controlled by protein synthesis, Nature, 534, 335, 10.1038/nature18282 Bohrer, 2010, Androgens suppress EZH2 expression via retinoblastoma (RB) and p130-dependent pathways: a potential mechanism of androgen-refractory progression of prostate cancer, Endocrinology, 151, 5136, 10.1210/en.2010-0436 Bokar, 1997, Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase, Rna, 3, 1233 Bononi, 2017, Germline BAP1 mutations induce a Warburg effect, Cell Death Differ., 24, 1694, 10.1038/cdd.2017.95 Booth, 2019, Neratinib and entinostat combine to rapidly reduce the expression of K-RAS, N-RAS, Galphaq and Galpha11 and kill uveal melanoma cells, Cancer Biol. Ther., 20, 700, 10.1080/15384047.2018.1551747 Bott, 2015, Oncogenic myc induces expression of glutamine synthetase through promoter demethylation, Cell Metabol., 22, 1068, 10.1016/j.cmet.2015.09.025 Bracken, 2003, EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer, EMBO J., 22, 5323, 10.1093/emboj/cdg542 Brantley, 2001, The molecular biology of retinoblastoma, Ocul. Immunol. Inflamm., 9, 1, 10.1076/ocii.9.1.1.3984 Brouwer, 2021, Conjunctival melanoma: new insights in tumour genetics and immunology, leading to new therapeutic options, Prog. Retin. Eye Res. Bruzzese, 2009, Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis, Mol. Cancer Therapeut., 8, 3075, 10.1158/1535-7163.MCT-09-0254 Busch, 2017, Reduction of the tumorigenic potential of human retinoblastoma cell lines by TFF1 overexpression involves p53/caspase signaling and miR-18a regulation, Int. J. Cancer, 141, 549, 10.1002/ijc.30768 Busch, 2019, p53, miR-34a and EMP1-newly identified targets of TFF3 signaling in Y79 retinoblastoma cells, Int. J. Mol. Sci., 20, 10.3390/ijms20174129 Cai, 2016, 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus, Sci. Rep., 6, 1 Calvaruso, 2001, Sodium phenylbutyrate induces apoptosis in human retinoblastoma Y79 cells: the effect of combined treatment with the topoisomerase I-inhibitor topotecan, Int. J. Oncol., 18, 1233 Candelaria, 2007, A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors, Ann. Oncol., 18, 1529, 10.1093/annonc/mdm204 Carlino, 2021, Immune checkpoint inhibitors in melanoma, Lancet, 398, 1002, 10.1016/S0140-6736(21)01206-X Carthew, 2009, Origins and Mechanisms of miRNAs and siRNAs, Cell, 136, 642, 10.1016/j.cell.2009.01.035 Carvalho, 2017, A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma, Cancer Biomarkers, 18, 313, 10.3233/CBM-160248 Castera, 2010, MDM2 as a modifier gene in retinoblastoma, J. Natl. Cancer Inst., 102, 1805, 10.1093/jnci/djq416 Castro-Magdonel, 2020, Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors, PLoS One, 15, 10.1371/journal.pone.0231394 Castro-Magdonel, 2017, miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma, BMC Cancer, 17, 458, 10.1186/s12885-017-3421-3 Chai, 2008, HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells, PLoS One, 3, e2445, 10.1371/journal.pone.0002445 Chai, 2018, Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis, Nucleic Acids Res., 46, 6041, 10.1093/nar/gky366 Chai, 2016, The evolving functions of autophagy in ocular health: a double-edged sword, Int. J. Biol. Sci., 12, 1332, 10.7150/ijbs.16245 Chai, 2020, Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis, Nucleic Acids Res., 48, 12135, 10.1093/nar/gkaa1051 Chan, 2016, Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancer, Radiother. Oncol., 119, 312, 10.1016/j.radonc.2016.04.013 Chang, 2003, Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer, J. Urol., 170, 595, 10.1097/01.ju.0000067626.37837.3e Chattopadhyay, 2016, Uveal melanoma: from diagnosis to treatment and the science in between, Cancer, 122, 2299, 10.1002/cncr.29727 Chen, 2017, HINT2 triggers mitochondrial Ca(2+) influx by regulating the mitochondrial Ca(2+) uniporter (MCU) complex and enhances gemcitabine apoptotic effect in pancreatic cancer, Cancer Lett., 411, 106, 10.1016/j.canlet.2017.09.020 Chen, 2013, MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 54, 2248, 10.1167/iovs.12-10977 Chen, 2019, 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs, Nat. Cell Biol., 21, 978, 10.1038/s41556-019-0361-y Cheng, 2016, HIC1 modulates uveal melanoma progression by activating lncRNA-numb, Tumour Biol., 37, 12779, 10.1007/s13277-016-5243-3 Cheng, 2017, Expression of EZH2 in uveal melanomas patients and associations with prognosis, Oncotarget, 8, 76423, 10.18632/oncotarget.19462 Chiappinelli, 2015, Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses, Cell, 162, 974, 10.1016/j.cell.2015.07.011 Chokhachi Baradaran, 2020, Targeting epigenetic modifications in uveal melanoma, Int. J. Mol. Sci., 21, 10.3390/ijms21155314 Choy, 2002, Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues, Invest. Ophthalmol. Vis. Sci., 43, 1344 Christman, 2002, 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy, Oncogene, 21, 5483, 10.1038/sj.onc.1205699 Chua, 2019, Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma, EMBO Mol. Med., 11, 10.15252/emmm.201809081 Clapier, 2009, The biology of chromatin remodeling complexes, Annu. Rev. Biochem., 78, 273, 10.1146/annurev.biochem.77.062706.153223 Cohen, 2008, Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma, Exp. Eye Res., 86, 201, 10.1016/j.exer.2007.10.010 Cohn, 1960, Pseudouridine, a carbon-carbon linked ribonucleoside in ribonucleic acids: isolation, structure, and chemical characteristics, J. Biol. Chem., 235, 1488, 10.1016/S0021-9258(18)69432-3 Coiffier, 2012, Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy, J. Clin. Oncol., 30, 631, 10.1200/JCO.2011.37.4223 Comings, 1973, A general theory of carcinogenesis, Proc. Natl. Acad. Sci. U. S. A., 70, 3324, 10.1073/pnas.70.12.3324 Conkrite, 2011, miR-17∼92 cooperates with RB pathway mutations to promote retinoblastoma, Genes Dev., 25, 1734, 10.1101/gad.17027411 1970, Central dogma of molecular biology, Nature, 227, 561, 10.1038/227561a0 Crick, 1958, On protein synthesis Cullen, 1993, Interaction between transcription regulatory regions of prolactin chromatin, Science, 261, 203, 10.1126/science.8327891 Dai, 2016, Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma, Sci. Rep., 6 Dai, 2018, RNA-binding protein trinucleotide repeat-containing 6A regulates the formation of circular RNA circ0006916, with important functions in lung cancer cells, Carcinogenesis, 39, 981, 10.1093/carcin/bgy061 Dalgard, 2009, Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells, Invest. Ophthalmol. Vis. Sci., 50, 4542, 10.1167/iovs.09-3520 Dalgard, 2008, Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma, Clin. Cancer Res., 14, 3113, 10.1158/1078-0432.CCR-07-4836 Damato, 2018, Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view, Prog. Retin. Eye Res., 66, 187, 10.1016/j.preteyeres.2018.03.004 Damato, 2011, Estimating prognosis for survival after treatment of choroidal melanoma, Prog. Retin. Eye Res., 30, 285, 10.1016/j.preteyeres.2011.05.003 Damato, 2012, Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients, Ophthalmology, 119, 1582, 10.1016/j.ophtha.2012.01.048 Danda, 2013, Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapy, PLoS One, 8, 10.1371/journal.pone.0083398 Das, 2020, Regulating methylation at H3K27: a trick or treat for cancer cell plasticity, Cancers, 12, 10.3390/cancers12102792 Daver, 2019, Efficacy, safety, and biomarkers of response to azacitidine and nivolumab in relapsed/refractory acute myeloid leukemia: a nonrandomized, open-label, phase II study, Cancer Discov., 9, 370, 10.1158/2159-8290.CD-18-0774 Decatur, 2016, Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes, JAMA Ophthalmol, 134, 728, 10.1001/jamaophthalmol.2016.0903 Dekker, 2002, Capturing chromosome conformation, Science, 295, 1306, 10.1126/science.1067799 Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017 Derrien, 2012, The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression, Genome Res., 22, 1775, 10.1101/gr.132159.111 Di Cerbo, 2013, Cancers with wrong HATs: the impact of acetylation, Briefings Funct. Genom., 12, 231, 10.1093/bfgp/els065 Dimaras, 2019, Retinoblastoma, the visible CNS tumor: a review, J. Neurosci. Res., 97, 29, 10.1002/jnr.24213 DiNardo, 2018, Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML, N. Engl. J. Med., 378, 2386, 10.1056/NEJMoa1716984 Ding, 2016, PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma, FEBS Lett., 590, 1729, 10.1002/1873-3468.12220 Doherty, 2017, Phenotypic plasticity in uveal melanoma is not restricted to a tumor subpopulation and is unrelated to cancer stem cell characteristics, Invest. Ophthalmol. Vis. Sci., 58, 5387, 10.1167/iovs.17-22272 Dominissini, 2012, Topology of the human and mouse m 6 A RNA methylomes revealed by m 6 A-seq, Nature, 485, 201, 10.1038/nature11112 Dominissini, 2016, The dynamic N 1-methyladenosine methylome in eukaryotic messenger RNA, Nature, 530, 441, 10.1038/nature16998 Dong, 2013, Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer, Cancer Cell, 23, 316, 10.1016/j.ccr.2013.01.022 Dong, 2012, MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets, Mol. Vis., 18, 537 Dratviman-Storobinsky, 2012, The role of RASSF1A in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 53, 2611, 10.1167/iovs.11-7730 Dryja, 1984, Homozygosity of chromosome 13 in retinoblastoma, N. Engl. J. Med., 310, 550, 10.1056/NEJM198403013100902 Du, 2016, Chromatin interactions and candidate genes at ten prostate cancer risk loci, Sci. Rep., 6 Dubin, 1975, The methylation state of poly A-containing-messenger RNA from cultured hamster cells, Nucleic Acids Res., 2, 1653, 10.1093/nar/2.10.1653 DuBois, 2015, Phase I study of vorinostat as a radiation sensitizer with 131I-metaiodobenzylguanidine (131I-MIBG) for patients with relapsed or refractory neuroblastoma, Clin. Cancer Res., 21, 2715, 10.1158/1078-0432.CCR-14-3240 Dunn, 1988, Identification of germline and somatic mutations affecting the retinoblastoma gene, Science, 241, 1797, 10.1126/science.3175621 Eissenberg, 2010, Histone H3 lysine 4 (H3K4) methylation in development and differentiation, Dev. Biol., 339, 240, 10.1016/j.ydbio.2009.08.017 El Annan, 2010, Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation, Invest. Ophthalmol. Vis. Sci., 51, 3418, 10.1167/iovs.09-3684 Engreitz, 2016, Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression, Nat. Rev. Mol. Cell Biol., 17, 756, 10.1038/nrm.2016.126 Esteller, 2008, Epigenetics in cancer, N. Engl. J. Med., 358, 1148, 10.1056/NEJMra072067 Ewens, 2017, Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma, Cancer Med., 6, 619, 10.1002/cam4.1010 Faiao-Flores, 2019, HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma, Clin. Cancer Res., 25, 5686, 10.1158/1078-0432.CCR-18-3382 Falzone, 2019, Prognostic significance of deregulated microRNAs in uveal melanomas, Mol. Med. Rep., 19, 2599 Fan, 2015, Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis, Genome Biol., 16, 139, 10.1186/s13059-015-0705-2 Fan, 2019, A cohesin-mediated intrachromosomal loop drives oncogenic ROR lncRNA to accelerate tumorigenesis, Mol. Ther., 27, 2182, 10.1016/j.ymthe.2019.07.020 Fang, 2010, A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer, Cancer, 116, 4043, 10.1002/cncr.25204 Fang, 2014, The novel, small-molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer, Clin. Cancer Res., 20, 6504, 10.1158/1078-0432.CCR-14-1553 Fenaux, 2009, Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study, Lancet Oncol., 10, 223, 10.1016/S1470-2045(09)70003-8 Field, 2018, Punctuated evolution of canonical genomic aberrations in uveal melanoma, Nat. Commun., 9, 116, 10.1038/s41467-017-02428-w Field, 2016, Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas, Oncotarget, 7, 59209, 10.18632/oncotarget.10962 Field, 2019, BAP1 loss is associated with DNA methylomic repatterning in highly aggressive class 2 uveal melanomas, Clin. Cancer Res., 25, 5663, 10.1158/1078-0432.CCR-19-0366 Figueroa, 2010, Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, 18, 553, 10.1016/j.ccr.2010.11.015 Friedman, 2009, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res., 19, 92, 10.1101/gr.082701.108 Fujisawa, 2017, Functions of bromodomain-containing proteins and their roles in homeostasis and cancer, Nat. Rev. Mol. Cell Biol., 18, 246, 10.1038/nrm.2016.143 Furney, 2013, SF3B1 mutations are associated with alternative splicing in uveal melanoma, Cancer Discov., 3, 1122, 10.1158/2159-8290.CD-13-0330 Gao, 2017, Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma, J. Transl. Med., 15, 268, 10.1186/s12967-017-1372-8 Gardner, 2014, c-MET expression in primary and liver metastases in uveal melanoma, Melanoma Res., 24, 617, 10.1097/CMR.0000000000000118 Giacinti, 2006, RB and cell cycle progression, Oncogene, 25, 5220, 10.1038/sj.onc.1209615 Giallongo, 2020, Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells, Aging, 12, 9745, 10.18632/aging.103241 Ginder, 1983, In vivo demethylation of chicken embryonic beta-type globin genes with 5-azacytidine, Prog. Clin. Biol. Res., 134, 501 Gollob, 2007, Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells, Clin. Cancer Res., 13, 5219, 10.1158/1078-0432.CCR-07-0816 Goncalves, 2020, Decitabine limits escape from MEK inhibition in uveal melanoma, Pigment Cell Melanoma Res, 33, 507, 10.1111/pcmr.12849 Goodall, 2021, RNA in cancer, Nat. Rev. Cancer, 21, 22, 10.1038/s41568-020-00306-0 Goodyear, 2010, Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia, Blood, 116, 1908, 10.1182/blood-2009-11-249474 Greer, 2012, Histone methylation: a dynamic mark in health, disease and inheritance, Nat. Rev. Genet., 313, 343, 10.1038/nrg3173 Guarnerio, 2016, Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations, Cell, 165, 289, 10.1016/j.cell.2016.03.020 Gunawardena, 2004, Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1, J. Biol. Chem., 279, 29278, 10.1074/jbc.M400395200 Guzman, 2020, Retinoblastoma tumor suppressor protein roles in epigenetic regulation, Cancers, 12, 10.3390/cancers12102807 Haas, 2014, Phase II trial of vorinostat in advanced melanoma, Invest. N. Drugs, 32, 526, 10.1007/s10637-014-0066-9 Han, 2019, METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner, Mol. Cancer, 18, 1, 10.1186/s12943-019-1036-9 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Harada, 2002, Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines, Cancer Res., 62, 5897 Harbour, 2010, Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, 330, 1410, 10.1126/science.1194472 Harbour, 2013, Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma, Nat. Genet., 45, 133, 10.1038/ng.2523 Harewood, 2017, Hi-C as a tool for precise detection and characterisation of chromosomal rearrangements and copy number variation in human tumours, Genome Biol., 18, 1, 10.1186/s13059-017-1253-8 Harland, 1988, Stability of RNA in developing Xenopus embryos and identification of a destabilizing sequence in TFIIIA messenger RNA, Development, 102, 837, 10.1242/dev.102.4.837 He, 2020, A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3, Mol. Cancer, 19, 115, 10.1186/s12943-020-01232-3 Hegi, 2005, MGMT gene silencing and benefit from temozolomide in glioblastoma, N. Engl. J. Med., 352, 997, 10.1056/NEJMoa043331 Heijkants, 2018, Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma, Oncotarget, 9, 6174, 10.18632/oncotarget.23485 Held, 2010, A role for the JARID1B stem cell marker for continuous melanoma growth, Pigment Cell Melanoma Res, 23, 481, 10.1111/j.1755-148X.2010.00726.x Herman, 2003, Gene silencing in cancer in association with promoter hypermethylation, N. Engl. J. Med., 349, 2042, 10.1056/NEJMra023075 Herwig-Carl, 2019, Spatial intratumor heterogeneity in uveal melanoma: tumor cell subtypes with a presumed invasive potential exhibit a particular epigenetic staining reaction, Exp. Eye Res., 182, 175, 10.1016/j.exer.2019.04.001 Hindie, 2021, Adjuvant therapy in stage IIIA melanoma, Lancet Oncol., 22, e299, 10.1016/S1470-2045(21)00346-6 Holliday, 1987, The inheritance of epigenetic defects, Science, 238, 163, 10.1126/science.3310230 Holling, 2007, A role for EZH2 in silencing of IFN-gamma inducible MHC2TA transcription in uveal melanoma, J. Immunol., 179, 5317, 10.4049/jimmunol.179.8.5317 Horsman, 1990, Monosomy 3 and isochromosome 8q in a uveal melanoma, Cancer Genet. Cytogenet., 45, 249, 10.1016/0165-4608(90)90090-W Hou, 2020, Machine learning-based integrative analysis of methylome and transcriptome identifies novel prognostic DNA methylation signature in uveal melanoma, Briefings Bioinf. Hou, 2019, The interplay of MicroRNA-34a, LGR4, EMT-associated factors, and MMP2 in regulating uveal melanoma cells, Invest. Ophthalmol. Vis. Sci., 60, 4503, 10.1167/iovs.18-26477 Hsiao, 2017, Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis, Cancer Res., 77, 2339, 10.1158/0008-5472.CAN-16-1883 Hu, 1993, Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes, Invest. Ophthalmol. Vis. Sci., 34, 2210 Huang, 2019, LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2, Eur. Rev. Med. Pharmacol. Sci., 23, 2880 Indovina, 2010, Downregulation and aberrant promoter methylation of p16INK4A: a possible novel heritable susceptibility marker to retinoblastoma, J. Cell. Physiol., 223, 143, 10.1002/jcp.22019 Inoue, 2016, Mutant IDH1 downregulates ATM and alters DNA repair and sensitivity to DNA damage independent of TET2, Cancer Cell, 30, 337, 10.1016/j.ccell.2016.05.018 Inoue, 2007, Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage, EMBO J., 26, 2083, 10.1038/sj.emboj.7601652 Ishak, 2016, An RB-EZH2 complex mediates silencing of repetitive DNA sequences, Mol. Cell, 64, 1074, 10.1016/j.molcel.2016.10.021 Issa, 2015, Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study, Lancet Oncol., 16, 1099, 10.1016/S1470-2045(15)00038-8 Iyer, 2015, The landscape of long noncoding RNAs in the human transcriptome, Nat. Genet., 47, 10.1038/ng.3192 Jager, 2018, The cancer genome Atlas Project: an integrated molecular view of uveal melanoma, Ophthalmology, 125, 1139, 10.1016/j.ophtha.2018.03.011 Jager, 2011, Macrophages in uveal melanoma and in experimental ocular tumor models: friends or foes?, Prog. Retin. Eye Res., 30, 129, 10.1016/j.preteyeres.2010.11.004 Jager, 2020, Uveal melanoma, Nat. Rev. Dis. Prim., 6, 24, 10.1038/s41572-020-0158-0 Jansen, 2019, Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastases, ESMO Open, 4, 10.1136/esmoopen-2018-000464 Javed, 2020, LncRNA & Wnt signaling in colorectal cancer, Cancer Cell Int., 20, 326, 10.1186/s12935-020-01412-7 Jeck, 2013, Circular RNAs are abundant, conserved, and associated with ALU repeats, Rna, 19, 141, 10.1261/rna.035667.112 Jenuwein, 2001, Translating the histone code, Science, 293, 1074, 10.1126/science.1063127 Jespersen, 2019, Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study, BMC Cancer, 19, 415, 10.1186/s12885-019-5623-3 Jespersen, 2019, Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study), Ann. Oncol., 30, v907, 10.1093/annonc/mdz394.068 Jia, 2011, N 6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO, Nat. Chem. Biol., 7, 885, 10.1038/nchembio.687 Jia, 2019, m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation, Mol. Cancer, 18, 161, 10.1186/s12943-019-1088-x Jia, 2017, Novel insights into chromosomal conformations in cancer, Mol. Cancer, 16, 173, 10.1186/s12943-017-0741-5 Jia, 2017, Novel insights into chromosomal conformations in cancer, Mol. Cancer, 16, 1, 10.1186/s12943-017-0741-5 Jin, 2020, Verification of EZH2 as a druggable target in metastatic uveal melanoma, Mol. Cancer, 19, 52, 10.1186/s12943-020-01173-x Jin, 2018, Neddylation blockade diminishes hepatic metastasis by dampening cancer stem-like cells and angiogenesis in uveal melanoma, Clin. Cancer Res., 24, 3741, 10.1158/1078-0432.CCR-17-1703 Jo, 2014, STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters, Oncotarget, 5, 11513, 10.18632/oncotarget.2546 Johnson, 2007, The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res., 67, 7713, 10.1158/0008-5472.CAN-07-1083 Johnson, 2005, RAS is regulated by the let-7 microRNA family, Cell, 120, 635, 10.1016/j.cell.2005.01.014 Jones, 2007, The epigenomics of cancer, Cell, 128, 683, 10.1016/j.cell.2007.01.029 Joshi, 2016, Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells, Clin. Exp. Metastasis, 33, 829, 10.1007/s10585-016-9815-9 Josling, 2012, The role of bromodomain proteins in regulating gene expression, Genes, 3, 320, 10.3390/genes3020320 Journee-de Korver, 2002, Thermotherapy in the management of choroidal melanoma, Prog. Retin. Eye Res., 21, 303, 10.1016/S1350-9462(02)00005-8 Kaliki, 2017, Uveal melanoma: relatively rare but deadly cancer, Eye, 31, 241, 10.1038/eye.2016.275 Kantarjian, 2006, Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study, Cancer, 106, 1794, 10.1002/cncr.21792 Karasawa, 2004, Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells, Jpn. J. Ophthalmol., 48, 542, 10.1007/s10384-004-0122-7 Karpf, 1999, Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells, Proc. Natl. Acad. Sci. U. S. A., 96, 14007, 10.1073/pnas.96.24.14007 Kashiwagi, 2010, Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines, Invest. Ophthalmol. Vis. Sci., 51, 679, 10.1167/iovs.09-4073 Kawano, 2010, Histone deacetylase inhibitors valproic acid and depsipeptide sensitize retinoblastoma cells to radiotherapy by increasing H2AX phosphorylation and p53 acetylation-phosphorylation, Int. J. Oncol., 37, 787 Khan, 2015, Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma, Lab. Invest., 95, 1278, 10.1038/labinvest.2015.104 Khoja, 2019, Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study, Ann. Oncol., 30, 1370, 10.1093/annonc/mdz176 Kilic, 2004, The RAS-BRAF kinase pathway is not involved in uveal melanoma, Melanoma Res., 14, 203, 10.1097/01.cmr.0000130006.46885.a0 Klein, 2010, The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia, Cancer Cell, 17, 28, 10.1016/j.ccr.2009.11.019 Klisovic, 2003, Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines, Invest. Ophthalmol. Vis. Sci., 44, 2390, 10.1167/iovs.02-1052 Klisovic, 2005, Depsipeptide inhibits migration of primary and metastatic uveal melanoma cell lines in vitro: a potential strategy for uveal melanoma, Melanoma Res., 15, 147, 10.1097/00008390-200506000-00002 Knudsen, 2019, Cell cycle and beyond: exploiting new RB1 controlled mechanisms for cancer therapy, Trends Cancer, 5, 308, 10.1016/j.trecan.2019.03.005 Knudson, 1971, Mutation and cancer: statistical study of retinoblastoma, Proc. Natl. Acad. Sci. U. S. A., 68, 820, 10.1073/pnas.68.4.820 Kooi, 2016, Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes, Sci. Rep., 6, 10.1038/srep25264 Kooi, 2015, Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression, EBioMedicine, 2, 660, 10.1016/j.ebiom.2015.06.022 Kouzarides, 2007, Chromatin modifications and their function, Cell, 128, 693, 10.1016/j.cell.2007.02.005 Krug, 1976, Influenza viral mRNA contains internal N6-methyladenosine and 5'-terminal 7-methylguanosine in cap structures, J. Virol., 20, 45, 10.1128/jvi.20.1.45-53.1976 Kuznetsoff, 2021, Dual screen for efficacy and toxicity identifies HDAC inhibitor with distinctive activity spectrum for BAP1-mutant uveal melanoma, Mol. Cancer Res., 19, 215, 10.1158/1541-7786.MCR-20-0434 LaFave, 2015, Loss of BAP1 function leads to EZH2-dependent transformation, Nat. Med., 21, 1344, 10.1038/nm.3947 Lajoie, 2015, The Hitchhiker's guide to Hi-C analysis: practical guidelines, Methods, 72, 65, 10.1016/j.ymeth.2014.10.031 Lamonica, 2006, Acetylation of GATA-1 is required for chromatin occupancy, Blood, 108, 3736, 10.1182/blood-2006-07-032847 Landreville, 2012, Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma, Clin. Cancer Res., 18, 408, 10.1158/1078-0432.CCR-11-0946 Larsen, 2014, MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma, Acta Ophthalmol., 92, 541, 10.1111/aos.12322 Laurent, 2011, High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients, Cancer Res., 71, 666, 10.1158/0008-5472.CAN-10-0605 Lawrence, 2016, Lateral thinking: how histone modifications regulate gene expression, Trends Genet., 32, 42, 10.1016/j.tig.2015.10.007 Leng, 2016, The neuropilin‐1 receptor mediates enhanced tumor delivery of H2K polyplexes, J. Gene Med., 18, 134, 10.1002/jgm.2886 Leng, 2008, Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation, Cancer Res., 68, 3049, 10.1158/0008-5472.CAN-07-6344 Li, 1993, Role for DNA methylation in genomic imprinting, Nature, 366, 362, 10.1038/366362a0 Li, 1992, Targeted mutation of the DNA methyltransferase gene results in embryonic lethality, Cell, 69, 915, 10.1016/0092-8674(92)90611-F Li, 2019, MALAT1 regulates miR-34a expression in melanoma cells, Cell Death Dis., 10, 389, 10.1038/s41419-019-1620-3 Li, 2020, lncRNA HotairM1 depletion promotes self-renewal of cancer stem cells through HOXA1-nanog regulation loop, Mol. Ther. Nucleic Acids, 22, 456, 10.1016/j.omtn.2020.09.008 Li, 2020, ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment, Proc. Natl. Acad. Sci. U. S. A., 117, 20159, 10.1073/pnas.1918986117 Li, 2020, ZNNT1 long noncoding RNA induces autophagy to inhibit tumorigenesis of uveal melanoma by regulating key autophagy gene expression, Autophagy, 16, 1186, 10.1080/15548627.2019.1659614 Li, 2017, NSUN2‐mediated m5C methylation and METTL3/METTL14‐mediated m6A methylation cooperatively enhance p21 translation, J. Cell. Biochem., 118, 2587, 10.1002/jcb.25957 Li, 2017, Coordinated circRNA biogenesis and function with NF90/NF110 in viral infection, Mol. Cell, 67, 214, 10.1016/j.molcel.2017.05.023 Li, 2016, HDACs and HDAC inhibitors in cancer development and therapy, Cold Spring Harb. Perspect. Med., 6, 10.1101/cshperspect.a026831 Li, 2019, Ras-PI3K-AKT signaling promotes the occurrence and development of uveal melanoma by downregulating H3K56ac expression, J. Cell. Physiol. Li, 2019, Ras-ERK1/2 signaling promotes the development of uveal melanoma by downregulating H3K14ac, J. Cell. Physiol. Liang, 2019, Translation of the circular RNA circbeta-catenin promotes liver cancer cell growth through activation of the Wnt pathway, Genome Biol., 20, 84, 10.1186/s13059-019-1685-4 Lin, 2016, The m6A methyltransferase METTL3 promotes translation in human cancer cells, Mol. Cell, 62, 335, 10.1016/j.molcel.2016.03.021 Liu, 2015, A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis, Cancer Cell, 27, 370, 10.1016/j.ccell.2015.02.004 Liu, 2020, Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin, Proc. Natl. Acad. Sci. U. S. A., 117, 33628, 10.1073/pnas.2011780117 Liu, 2013, Tumor-targeting TRAIL expression mediated by miRNA response elements suppressed growth of uveal melanoma cells, Mol. Oncol., 7, 1043, 10.1016/j.molonc.2013.08.003 Liu, 2014, MIR34A regulates autophagy and apoptosis by targeting HMGB1 in the retinoblastoma cell, Autophagy, 10, 442, 10.4161/auto.27418 Liu, 2015, N 6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions, Nature, 518, 560, 10.1038/nature14234 Liu, 2014, 5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene, Int. J. Ophthalmol., 7, 51 Liu, 2021, Circ_0119872 promotes uveal melanoma development by regulating the miR-622/G3BP1 axis and downstream signalling pathways, J. Exp. Clin. Cancer Res., 40, 66, 10.1186/s13046-021-01833-w Liu, 2014, Plasma microRNA-320, microRNA-let-7e and microRNA-21 as novel potential biomarkers for the detection of retinoblastoma, Biomed. Rep., 2, 424, 10.3892/br.2014.246 Liu, 2019, GDF11 upregulation independently predicts shorter overall-survival of uveal melanoma, PLoS One, 14 Liu, 2018, MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect, Biochem. Biophys. Res. Commun., 501, 885, 10.1016/j.bbrc.2018.05.069 Livide, 2012, Epigenetic and copy number variation analysis in retinoblastoma by MS-MLPA, Pathol. Oncol. Res., 18, 703, 10.1007/s12253-012-9498-8 Lodygin, 2008, Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer, Cell Cycle, 7, 2591, 10.4161/cc.7.16.6533 Lovén, 2013, Selective inhibition of tumor oncogenes by disruption of super-enhancers, Cell, 153, 320, 10.1016/j.cell.2013.03.036 Lu, 2017, The long non-coding RNA RHPN1-AS1 promotes uveal melanoma progression, Int. J. Mol. Sci., 18, 10.3390/ijms18010226 Lu, 2017, LncRNA HOXA11-AS exerts oncogenic functions by repressing p21 and miR-124 in uveal melanoma, DNA Cell Biol., 36, 837, 10.1089/dna.2017.3808 Lu, 2020, Reprogramming to recover youthful epigenetic information and restore vision, Nature, 588, 124, 10.1038/s41586-020-2975-4 Luo, 1998, Rb interacts with histone deacetylase to repress transcription, Cell, 92, 463, 10.1016/S0092-8674(00)80940-X Luo, 2016, Carvacrol alleviates prostate cancer cell proliferation, migration, and invasion through regulation of PI3K/Akt and MAPK signaling pathways, Oxidat. Med. Cell. Longev., 2016, 10.1155/2016/1469693 Lyu, 2019, Reduction of circular RNA expression associated with human retinoblastoma, Exp. Eye Res., 184, 278, 10.1016/j.exer.2019.03.017 Maat, 2008, Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 49, 1291, 10.1167/iovs.07-1135 Maat, 2008, Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma, Invest. Ophthalmol. Vis. Sci., 49, 23, 10.1167/iovs.07-0722 Maat, 2007, Epigenetic inactivation of RASSF1a in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 48, 486, 10.1167/iovs.06-0781 Maelandsmo, 1997, Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma, Int. J. Cancer, 74, 464, 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9 Malusa, 2015, Time-course gene profiling and networks in demethylated retinoblastoma cell line, Oncotarget, 6, 23688, 10.18632/oncotarget.4644 Marmorstein, 2014, Writers and readers of histone acetylation: structure, mechanism, and inhibition, Cold Spring Harbor Perspect. Biol., 6, 10.1101/cshperspect.a018762 Martin, 2006, Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma, Gastroenterology, 130, 2179, 10.1053/j.gastro.2006.03.024 Martin, 2013, Disruption of the histidine triad nucleotide-binding hint2 gene in mice affects glycemic control and mitochondrial function, Hepatology, 57, 2037, 10.1002/hep.26060 Martin, 2017, HUGIn: Hi-C unifying genomic interrogator, Bioinformatics, 33, 3793, 10.1093/bioinformatics/btx359 Martin, 2013, Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nat. Genet., 45, 933, 10.1038/ng.2674 Marzi, 2012, Differentiation-associated microRNAs antagonize the Rb-E2F pathway to restrict proliferation, J. Cell Biol., 199, 77, 10.1083/jcb.201206033 Mashtalir, 2018, Modular organization and assembly of SWI/SNF family chromatin remodeling complexes, Cell, 175, 1272, 10.1016/j.cell.2018.09.032 McClure, 2018, Advances and challenges of HDAC inhibitors in cancer therapeutics, Adv. Cancer Res., 138, 183, 10.1016/bs.acr.2018.02.006 McEvoy, 2014, RB1 gene inactivation by chromothripsis in human retinoblastoma, Oncotarget, 5, 438, 10.18632/oncotarget.1686 McEvoy, 2015, Genetic and epigenetic discoveries in human retinoblastoma, Crit. Rev. Oncog., 20, 217, 10.1615/CritRevOncog.2015013711 McLaughlin-Drubin, 2013, Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines, Proc. Natl. Acad. Sci. U. S. A., 110, 16175, 10.1073/pnas.1310432110 Medina, 2010, OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma, Nature, 467, 86, 10.1038/nature09284 Memczak, 2013, Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, 495, 333, 10.1038/nature11928 Mensink, 2008, Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome, Cancer Genet. Cytogenet., 181, 108, 10.1016/j.cancergencyto.2007.12.001 Meyer, 2015, 5′ UTR m6A promotes cap-independent translation, Cell, 163, 999, 10.1016/j.cell.2015.10.012 Michalak, 2019, The roles of DNA, RNA and histone methylation in ageing and cancer, Nat. Rev. Mol. Cell Biol., 20, 573, 10.1038/s41580-019-0143-1 Michlewski, 2019, Post-transcriptional control of miRNA biogenesis, RNA, 25, 1, 10.1261/rna.068692.118 Mishra, 2020, Inflammasomes in cancer: effect of epigenetic and autophagic modulations, Semin. Cancer Biol. Munier, 2019, Conservative management of retinoblastoma: challenging orthodoxy without compromising the state of metastatic grace. "Alive, with good vision and no comorbidity, Prog. Retin. Eye Res., 73, 10.1016/j.preteyeres.2019.05.005 Nebbioso, 2018, Cancer epigenetics: moving forward, PLoS Genet., 14, 10.1371/journal.pgen.1007362 Nencetti, 2021, Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines, J. Enzym. Inhib. Med. Chem., 36, 34, 10.1080/14756366.2020.1835883 Nevedomskaya, 2016, Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer, Genom Data, 7, 124, 10.1016/j.gdata.2015.12.020 Ni, 2020, LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter, Cell Death Dis., 11, 306, 10.1038/s41419-020-2524-y Niederkorn, 2009, Immune escape mechanisms of intraocular tumors, Prog. Retin. Eye Res., 28, 329, 10.1016/j.preteyeres.2009.06.002 Niesen, 2009, Rescue of major histocompatibility-DR surface expression in retinoblastoma-defective, non-small cell lung carcinoma cells by the MS-275 histone deacetylase inhibitor, Biol. Pharm. Bull., 32, 480, 10.1248/bpb.32.480 Nittner, 2012, Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation, Nat. Cell Biol., 14, 958, 10.1038/ncb2556 O'Connor, 2015, Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: results of the pivotal phase II BELIEF (CLN-19) study, J. Clin. Oncol., 33, 2492, 10.1200/JCO.2014.59.2782 Ohtani-Fujita, 1997, Hypermethylation in the retinoblastoma gene is associated with unilateral, sporadic retinoblastoma, Cancer Genet. Cytogenet., 98, 43, 10.1016/S0165-4608(96)00395-0 Okano, 1999, DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, Cell, 99, 247, 10.1016/S0092-8674(00)81656-6 Olsen, 2007, Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma, J. Clin. Oncol., 25, 3109, 10.1200/JCO.2006.10.2434 Orillion, 2017, Entinostat neutralizes myeloid-derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma, Clin. Cancer Res., 23, 5187, 10.1158/1078-0432.CCR-17-0741 Osborne, 2004, Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter, J. Biol. Chem., 279, 28911, 10.1074/jbc.M403118200 Pan, 2015, BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells, Int. J. Biochem. Cell Biol., 60, 176, 10.1016/j.biocel.2015.01.001 Pan, 2016, P2RX7-V3 is a novel oncogene that promotes tumorigenesis in uveal melanoma, Tumour Biol., 37, 13533, 10.1007/s13277-016-5141-8 Pekarsky, 2010, Is miR-29 an oncogene or tumor suppressor in CLL?, Oncotarget, 1, 224, 10.18632/oncotarget.129 Peng, 2019, MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers, Cancer Med., 8, 7161, 10.1002/cam4.2583 Philippeit, 2014, Epigenetic control of trefoil factor family (TFF) peptide expression in human retinoblastoma cell lines, Cell. Physiol. Biochem., 34, 1001, 10.1159/000366316 Piekarz, 2011, Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma, Blood, 117, 5827, 10.1182/blood-2010-10-312603 Piekarz, 2009, Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma, J. Clin. Oncol., 27, 5410, 10.1200/JCO.2008.21.6150 Poulaki, 2009, Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications, Invest. Ophthalmol. Vis. Sci., 50, 4072, 10.1167/iovs.09-3517 Poulaki, 2005, Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing, Invest. Ophthalmol. Vis. Sci., 46, 358, 10.1167/iovs.04-0324 Prebet, 2014, Prolonged administration of azacitidine with or without entinostat for myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes: results of the US Leukemia Intergroup trial E1905, J. Clin. Oncol., 32, 1242, 10.1200/JCO.2013.50.3102 Prensner, 2013, The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex, Nat. Genet., 45, 1392, 10.1038/ng.2771 Qi, 2020, Long non-coding RNA GAS5 targeting microRNA-21 to suppress the invasion and epithelial-mesenchymal transition of uveal melanoma, Cancer Manag. Res., 12, 12259, 10.2147/CMAR.S260866 Qi, 2020, Knockdown of long non-coding RNA LOC100132707 inhibits the migration of uveal melanoma cells via silencing JAK2, OncoTargets Ther., 13, 12955, 10.2147/OTT.S266596 Radberger, 2012, JARID1B protein expression and prognostic implications in uveal melanoma, Invest. Ophthalmol. Vis. Sci., 53, 4442, 10.1167/iovs.11-9296 Radhakrishnan, 2009, Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma, Mol. Vis., 15, 2146 Radosevich, 2007, Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator, Exp. Mol. Pathol., 82, 68, 10.1016/j.yexmp.2006.03.005 Rago, 2020, The discovery of SWI/SNF chromatin remodeling activity as a novel and targetable dependency in uveal melanoma, Mol. Cancer Therapeut., 19, 2186, 10.1158/1535-7163.MCT-19-1013 Ragusa, 2015, miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: pathological and diagnostic implications, Cancer Biol. Ther., 16, 1387, 10.1080/15384047.2015.1046021 Raizis, 2020, DNA hypermethylation/boundary control loss identified in retinoblastomas associated with genetic and epigenetic inactivation of the RB1 gene promoter, Epigenetics, 1 Rajaii, 2014, The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma, Invest. Ophthalmol. Vis. Sci., 55, 6178, 10.1167/iovs.14-13933 Rajasekaran, 2019, Non-coding and coding transcriptional profiles are significantly altered in pediatric retinoblastoma tumors, Front. Oncol., 9, 221, 10.3389/fonc.2019.00221 Rao, 2014, A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping, Cell, 159, 1665, 10.1016/j.cell.2014.11.021 Reik, 2007, Stability and flexibility of epigenetic gene regulation in mammalian development, Nature, 447, 425, 10.1038/nature05918 Reik, 2001, Epigenetic reprogramming in mammalian development, Science, 293, 1089, 10.1126/science.1063443 Reik, 2001, Genomic imprinting: parental influence on the genome, Nat. Rev. Genet., 2, 21, 10.1038/35047554 Robertson, 2017, Integrative analysis identifies four molecular and clinical subsets in uveal melanoma, Cancer Cell, 32, 204, 10.1016/j.ccell.2017.07.003 Robertson, 2017, Integrative analysis identifies four molecular and clinical subsets in uveal melanoma, Cancer Cell, 33, 151, 10.1016/j.ccell.2017.12.013 Robertson, 2018, Integrative analysis identifies four molecular and clinical subsets in uveal melanoma, Cancer Cell, 33, 151, 10.1016/j.ccell.2017.12.013 Robertson, 2005, DNA methylation and human disease, Nat. Rev. Genet., 6, 597, 10.1038/nrg1655 Rosenfeld, 2009, Determination of enriched histone modifications in non-genic portions of the human genome, BMC Genom., 10, 143, 10.1186/1471-2164-10-143 Rossi, 2019, Immunological backbone of uveal melanoma: is there a rationale for immunotherapy?, Cancers, 11, 10.3390/cancers11081055 Rushlow, 2013, Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies, Lancet Oncol., 14, 327, 10.1016/S1470-2045(13)70045-7 Russo, 2016, Increased levels of miRNA-146a in serum and histologic samples of patients with uveal melanoma, Front. Pharmacol., 7, 424, 10.3389/fphar.2016.00424 Sabari, 2018, Coactivator condensation at super-enhancers links phase separation and gene control, Science, 361, 10.1126/science.aar3958 Sabari, 2017, Metabolic regulation of gene expression through histone acylations, Nat. Rev. Mol. Cell Biol., 18, 90, 10.1038/nrm.2016.140 Saengwimol, 2020, Silencing of the long noncoding RNA MYCNOS1 suppresses activity of MYCN-amplified retinoblastoma without RB1 mutation, Invest. Ophthalmol. Vis. Sci., 61, 8, 10.1167/iovs.61.14.8 Sakai, 1991, Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene, Am. J. Hum. Genet., 48, 880 Salzman, 2013, Cell-type specific features of circular RNA expression, PLoS Genet., 9, 10.1371/annotation/f782282b-eefa-4c8d-985c-b1484e845855 Salzman, 2012, Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types, PLoS One, 7, 10.1371/journal.pone.0030733 San-Miguel, 2014, Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial, Lancet Oncol., 15, 1195, 10.1016/S1470-2045(14)70440-1 Satoh, 2004, Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells, Oncogene, 23, 8876, 10.1038/sj.onc.1208144 Sawan, 2010, Histone modifications and cancer, Adv. Genet., 70, 57, 10.1016/B978-0-12-380866-0.60003-4 Schoumacher, 2016, Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status, Nat. Med., 22, 577, 10.1038/nm.4098 Schreiber, 2002, Signaling network model of chromatin, Cell, 111, 771, 10.1016/S0092-8674(02)01196-0 Schwanhäusser, 2011, Global quantification of mammalian gene expression control, Nature, 473, 337, 10.1038/nature10098 Shang, 2019, The novel roles of circRNAs in human cancer, Mol. Cancer, 18, 1, 10.1186/s12943-018-0934-6 Shi, 2020, Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation, Mol. Cancer, 19, 1, 10.1186/s12943-020-01194-6 Shi, 2020, Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation, Mol. Cancer, 19, 78, 10.1186/s12943-020-01194-6 Shi, 2017, Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China, J. Hematol. Oncol., 10, 69, 10.1186/s13045-017-0439-6 Shields, 2017, Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 harry S. Gradle lecture, Ophthalmology, 124, 1523, 10.1016/j.ophtha.2017.04.003 Shilatifard, 2012, The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis, Annu. Rev. Biochem., 81, 65, 10.1146/annurev-biochem-051710-134100 Shimada, 2012, ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals, Clin. Cancer Res., 18, 5247, 10.1158/1078-0432.CCR-12-0955 Shintani, 2004, Autophagy in health and disease: a double-edged sword, Science, 306, 990, 10.1126/science.1099993 Silverman, 2002, Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B, J. Clin. Oncol., 20, 2429, 10.1200/JCO.2002.04.117 Singh, 2010, Nonhistone protein acetylation as cancer therapy targets, Expet Rev. Anticancer Ther., 10, 935, 10.1586/era.10.62 Singh, 2018, Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors, Proc. Natl. Acad. Sci. U. S. A., 115, E9391, 10.1073/pnas.1808903115 Smit, 2019, Aberrant MicroRNA expression and its implications for uveal melanoma metastasis, Cancers, 11, 10.3390/cancers11060815 Smit, 2020, Uveal melanoma: towards a molecular understanding, Prog. Retin. Eye Res., 75, 10.1016/j.preteyeres.2019.100800 Sommer, 1976, The methylation of adenovirus-specific nuclear and cytoplasmic RNA, Nucleic Acids Res., 3, 749, 10.1093/nar/3.3.749 Souri, 2020, HDAC inhibition increases HLA class I expression in uveal melanoma, Cancers, 12, 10.3390/cancers12123690 Souri, 2021, Expression of HDACs 1, 3 and 8 is upregulated in the presence of infiltrating lymphocytes in uveal melanoma, Cancers, 13, 10.3390/cancers13164146 Souri, 2021, MiRNAs correlate with HLA expression in uveal melanoma: both up- and downregulation are related to monosomy 3, Cancers, 13, 10.3390/cancers13164020 Squires, 2012, Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA, Nucleic Acids Res., 40, 5023, 10.1093/nar/gks144 Stark, 2019, A panel of circulating MicroRNAs detects uveal melanoma with high precision, Transl. Vis. Sci. Technol., 8, 12, 10.1167/tvst.8.6.12 Stein-Streilein, 2002, Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy, Int. Rev. Immunol., 21, 123, 10.1080/08830180212066 Stein, 2019, Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib, Blood, 133, 676, 10.1182/blood-2018-08-869008 Stirzaker, 1997, Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors, Cancer Res., 57, 2229 Stone, 2017, Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden, Proc. Natl. Acad. Sci. U. S. A., 114, E10981, 10.1073/pnas.1712514114 Strub, 2021, Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology, Prog. Retin. Eye Res., 10.1016/j.preteyeres.2021.100968 Stuart, 1997, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival, J. Clin. Invest., 99, 396, 10.1172/JCI119173 Subramanian, 2015, Blocking the maturation of OncomiRNAs using pri-miRNA-17 approximately 92 aptamer in retinoblastoma, Nucleic Acid Therapeut., 25, 47, 10.1089/nat.2014.0507 Sun, 2020, Biomarkers in retinoblastoma, Int. J. Ophthalmol., 13, 325, 10.18240/ijo.2020.02.18 Sun, 2016, Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140, Am. J. Transl. Res., 8, 3939 Taby, 2010, Cancer epigenetics, Ca - Cancer J. Clin., 60, 376, 10.3322/caac.20085 Takayama, 2007, Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis, Oncogene, 26, 4453, 10.1038/sj.onc.1210229 Tang, 2015, NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation, Aging, 7, 1143, 10.18632/aging.100860 Tang, 2021, lncRNA GAU1 induces GALNT8 overexpression and potentiates colorectal cancer progression, Gastroenterol. Res. Pract., 2021, 10.1155/2021/5960821 Taylor, 2007, Ocular immunosuppressive microenvironment, Chem. Immunol. Allergy, 92, 71, 10.1159/000099255 Terui, 2003, Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors, Cancer Res., 63, 8948 Thill, 2011, Expression of CD133 and other putative stem cell markers in uveal melanoma, Melanoma Res., 21, 405, 10.1097/CMR.0b013e328348db10 Thottassery, 2014, Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine, Cancer Chemother. Pharmacol., 74, 291, 10.1007/s00280-014-2503-z Tian, 2020, Identification of microRNA-mRNA regulatory networks and pathways related to retinoblastoma across human and mouse, Int. J. Ophthalmol., 13, 535, 10.18240/ijo.2020.04.02 To, 2012, Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development, BMC Cancer, 12, 69, 10.1186/1471-2407-12-69 Tommasi, 2005, Tumor susceptibility of Rassf1a knockout mice, Cancer Res., 65, 92, 10.1158/0008-5472.92.65.1 Topper, 2017, Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer, Cell, 171, 1284, 10.1016/j.cell.2017.10.022 Topper, 2020, The emerging role of epigenetic therapeutics in immuno-oncology, Nat. Rev. Clin. Oncol., 17, 75, 10.1038/s41571-019-0266-5 Tosi, 2005, Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach, Oncogene, 24, 5827, 10.1038/sj.onc.1208630 Triozzi, 2016, Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma, Clin. Epigenet., 8, 80, 10.1186/s13148-016-0243-0 Truong, 2020, Chloroquine sensitizes GNAQ/11-mutated melanoma to MEK1/2 inhibition, Clin. Cancer Res., 26, 6374, 10.1158/1078-0432.CCR-20-1675 Tsai, 2010, Long noncoding RNA as modular scaffold of histone modification complexes, Science, 329, 689, 10.1126/science.1192002 Turcan, 2012, IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype, Nature, 483, 479, 10.1038/nature10866 Uchida, 2005, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, EMBO J., 24, 160, 10.1038/sj.emboj.7600486 van der Ent, 2014, Modeling of human uveal melanoma in zebrafish xenograft embryos, Invest. Ophthalmol. Vis. Sci., 55, 6612, 10.1167/iovs.14-15202 van der Velden, 2001, Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma, Cancer Res., 61, 5303 van der Velden, 2003, Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development, Int. J. Cancer, 106, 472, 10.1002/ijc.11262 van Poppelen, 2019, SRSF2 mutations in uveal melanoma: a preference for in-frame deletions?, Cancers, 11, 10.3390/cancers11081200 Van Raamsdonk, 2009, Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, 457, 599, 10.1038/nature07586 Van Raamsdonk, 2010, Mutations in GNA11 in uveal melanoma, N. Engl. J. Med., 363, 2191, 10.1056/NEJMoa1000584 Vashishtha, 2020, Changes in microRNA expression associated with metastasis and survival in patients with uveal melanoma, Oncotarget, 11, 1435, 10.18632/oncotarget.27559 Venkatesan, 2016, Clinico-pathological association of delineated miRNAs in uveal melanoma with monosomy 3/disomy 3 chromosomal aberrations, PLoS One, 11, 10.1371/journal.pone.0146128 Venza, 2013, Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells, Pigment Cell Melanoma Res, 26, 193, 10.1111/pcmr.12049 Venza, 2014, Class I-specific histone deacetylase inhibitor MS-275 overrides TRAIL-resistance in melanoma cells by downregulating c-FLIP, Int. Immunopharm., 21, 439, 10.1016/j.intimp.2014.05.024 Venza, 2016, miR-92a-3p and MYCBP2 are involved in MS-275-induced and c-myc-mediated TRAIL-sensitivity in melanoma cells, Int. Immunopharm., 40, 235, 10.1016/j.intimp.2016.09.004 Venza, 2015, Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma, Biochim. Biophys. Acta, 1849, 247, 10.1016/j.bbagrm.2014.12.004 Venza, 2017, DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients, Hum. Pathol., 60, 137, 10.1016/j.humpath.2016.10.018 Venza, 2016, DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma, Oncol. Rep., 35, 2451, 10.3892/or.2016.4618 Venza, 2015, The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma, Int. Immunopharm., 28, 313, 10.1016/j.intimp.2015.06.024 Villegas, 2013, Retinoblastoma, Curr. Opin. Ophthalmol., 24, 581, 10.1097/ICU.0000000000000002 Vo, 2019, The landscape of circular RNA in cancer, Cell, 176, 869, 10.1016/j.cell.2018.12.021 Voelter, 2008, Infrequent promoter methylation of the MGMT gene in liver metastases from uveal melanoma, Int. J. Cancer, 123, 1215, 10.1002/ijc.23632 Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc. Natl. Acad. Sci. Unit. States Am., 103, 2257, 10.1073/pnas.0510565103 Wang, 2014, An intragenic long noncoding RNA interacts epigenetically with the RUNX1 promoter and enhancer chromatin DNA in hematopoietic malignancies, Int. J. Cancer, 135, 2783, 10.1002/ijc.28922 Wang, 2018, Long noncoding RNA DANCR aggravates retinoblastoma through miR-34c and miR-613 by targeting MMP-9, J. Cell. Physiol., 233, 6986, 10.1002/jcp.26621 Wang, 2018, Epigenomics: technologies and applications, Circ. Res., 122, 1191, 10.1161/CIRCRESAHA.118.310998 Wang, 2008, miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130, Proc. Natl. Acad. Sci. U. S. A., 105, 2889, 10.1073/pnas.0800178105 Wang, 2019, PVT1 promotes cancer progression via MicroRNAs, Front. Oncol., 9, 609, 10.3389/fonc.2019.00609 Wang, 2017, In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor, Cancer Lett., 400, 47, 10.1016/j.canlet.2017.04.028 Ward, 2010, The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate, Cancer Cell, 17, 225, 10.1016/j.ccr.2010.01.020 Ward, 2020, Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival, Br. J. Dermatol., 183, 163, 10.1111/bjd.18881 Wei, 1975, Methylated nucleotides block 5′ terminus of HeLa cell messenger RNA, Cell, 4, 379, 10.1016/0092-8674(75)90158-0 Wen, 2016, Orchestrating epigenetic roles targeting ocular tumors, OncoTargets Ther., 9, 1001 Wilson, 2011, SWI/SNF nucleosome remodellers and cancer, Nat. Rev. Cancer, 11, 481, 10.1038/nrc3068 Woo, 2019, Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells, Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms, 1862, 35, 10.1016/j.bbagrm.2018.10.008 Woo, 2019, Human ALKBH3-induced m(1)A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells, Biochim Biophys Acta Gene Regul Mech, 1862, 35, 10.1016/j.bbagrm.2018.10.008 Worley, 2008, Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling, Melanoma Res., 18, 184, 10.1097/CMR.0b013e3282feeac6 Wroblewska, 2020, The potential role of selected miRNA in uveal melanoma primary tumors as early biomarkers of disease progression, Genes, 11, 10.3390/genes11030271 Wu, 2011, Androgen receptor-driven chromatin looping in prostate cancer, Trends Endocrinol. Metabol., 22, 474, 10.1016/j.tem.2011.07.006 Wu, 2020, Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis, Cancer Cell Int., 20, 201, 10.1186/s12935-020-01281-0 Wu, 2019, Translation of yes-associated protein (YAP) was antagonized by its circular RNA via suppressing the assembly of the translation initiation machinery, Cell Death Differ., 26, 2758, 10.1038/s41418-019-0337-2 Wu, 2020, Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4, Am. J. Physiol. Cell Physiol., 318, C903, 10.1152/ajpcell.00262.2019 Wu, 2020, lncRNA SNHG7 affects malignant tumor behaviors through downregulation of EZH2 in uveal melanoma cell lines, Oncol. Lett., 19, 1505 Xiang, 2014, Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus, Cell Res., 24, 513, 10.1038/cr.2014.35 Xin, 2019, Identification of a nine-miRNA signature for the prognosis of Uveal Melanoma, Exp. Eye Res., 180, 242, 10.1016/j.exer.2019.01.004 Xing, 2018, Downregulation of circular RNA hsa_circ_0001649 indicates poor prognosis for retinoblastoma and regulates cell proliferation and apoptosis via AKT/mTOR signaling pathway, Biomed. Pharmacother., 105, 326, 10.1016/j.biopha.2018.05.141 Xing, 2017, CANT1 lncRNA triggers efficient therapeutic efficacy by correcting aberrant lncing cascade in malignant uveal melanoma, Mol. Ther., 25, 1209, 10.1016/j.ymthe.2017.02.016 Xu, 2018, Genome-wide analysis of uveal melanoma metastasis-associated LncRNAs and their functional network, DNA Cell Biol., 37, 99, 10.1089/dna.2017.4015 Xu, 2017, High expression of lncRNA PVT1 independently predicts poor overall survival in patients with primary uveal melanoma, PLoS One, 12, 10.1371/journal.pone.0189675 Xu, 2016, ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma, Cancer Lett., 381, 41, 10.1016/j.canlet.2016.07.024 Xu, 2009, Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling, Cell, 137, 1018, 10.1016/j.cell.2009.03.051 Xu, 2014, Rb suppresses human cone-precursor-derived retinoblastoma tumours, Nature, 514, 385, 10.1038/nature13813 Xu, 2020, Epidemiological study of uveal melanoma from US surveillance, epidemiology, and end results program (2010-2015), J. Ophthalmol., 2020, 10.1155/2020/3614039 Xu, 2020, The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer, Cell Prolif, 53, 10.1111/cpr.12770 Yan, 2009, MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met, Invest. Ophthalmol. Vis. Sci., 50, 1559, 10.1167/iovs.08-2681 Yang, 2021, Emerging roles of microRNAs and their implications in uveal melanoma, Cell. Mol. Life Sci., 78, 545, 10.1007/s00018-020-03612-w Yang, 2011, The miRNA expression profile of the uveal melanoma, Sci. China Life Sci., 54, 351, 10.1007/s11427-011-4149-y Yang, 2019, The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression, Mol. Cancer, 18, 4, 10.1186/s12943-018-0933-7 Yang, 2019, m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade, Nat. Commun., 10, 2782, 10.1038/s41467-019-10669-0 Yang, 2018, Novel circular RNA expression profile of uveal melanoma revealed by microarray, Chin. J. Cancer Res., 30, 656, 10.21147/j.issn.1000-9604.2018.06.10 Yang, 2017, 5-methylcytosine promotes mRNA export—NSUN2 as the methyltransferase and ALYREF as an m 5 C reader, Cell Res., 27, 606, 10.1038/cr.2017.55 Yang, 2015, miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression, Mol. Vis., 21, 1307 Yavuzyigitoglu, 2016, Uveal melanomas with SF3B1 mutations: a distinct subclass Associated with late-onset metastases, Ophthalmology, 123, 1118, 10.1016/j.ophtha.2016.01.023 Yoon, 2012, LincRNA-p21 suppresses target mRNA translation, Mol. Cell, 47, 648, 10.1016/j.molcel.2012.06.027 Youn, 2013, Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer, Nat. Immunol., 14, 211, 10.1038/ni.2526 Yu, 2020, A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis, Life Sci., 260, 10.1016/j.lfs.2020.118409 Yu, 2021, Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma, Genome Biol., 22, 85, 10.1186/s13059-021-02308-z Yu, 2020, Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells, Oncol. Lett., 19, 460 Yu, 2020, Pontin arginine methylation by CARM1 is crucial for epigenetic regulation of autophagy, Nat. Commun., 11, 6297, 10.1038/s41467-020-20080-9 Zeng, 2021, The methylation level of TFAP2A is a potential diagnostic biomarker for retinoblastoma: an analytical validation study, PeerJ, 9, 10.7717/peerj.10830 Zeng, 2020, Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma, Medicine (Baltim.), 99 Zhang, 2019, Metabolic regulation of gene expression by histone lactylation, Nature, 574, 575, 10.1038/s41586-019-1678-1 Zhang, 2013, Methylation of RASSF1A gene promoter is regulated by p53 and DAXX, Faseb. J., 27, 232, 10.1096/fj.12-215491 Zhang, 2020, m(6)A methyltransferase METTL3 promotes retinoblastoma progression via PI3K/AKT/mTOR pathway, J. Cell Mol. Med., 24, 12368, 10.1111/jcmm.15736 Zhang, 2012, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, 481, 329, 10.1038/nature10733 Zhang, 2018, The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma, J. Exp. Clin. Cancer Res., 37, 15, 10.1186/s13046-018-0679-5 Zhang, 2019, MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer, J. Exp. Clin. Cancer Res., 38, 53, 10.1186/s13046-019-1059-5 Zhang, 2021, A multi-omics study on cutaneous and uveal melanoma, Int. J. Ophthalmol., 14, 32, 10.18240/ijo.2021.01.05 Zhang, 2021, Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity, Semin. Cancer Biol. Zhang, 2020, Downregulation of MST4 underlies a novel inhibitory role of MicroRNA let-7a in the progression of retinoblastoma, Invest. Ophthalmol. Vis. Sci., 61, 28, 10.1167/iovs.61.6.28 Zhang, 2018, Analysis of the androgen receptor–regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression, Nat. Genet., 50, 814, 10.1038/s41588-018-0120-1 Zhang, 2014, Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer, Epigenetics, 9, 896, 10.4161/epi.28601 Zhao, 2009, Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis, Childs Nerv. Syst., 25, 13, 10.1007/s00381-008-0701-x Zhao, 2019, m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer, Transl. Oncol., 12, 1323, 10.1016/j.tranon.2019.06.007 Zhao, 2019, m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer, Transl. Oncol., 12, 1323, 10.1016/j.tranon.2019.06.007 Zheng, 2013, ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility, Mol. Cell, 49, 18, 10.1016/j.molcel.2012.10.015 Zheng, 2016, Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs, Nat. Commun., 7, 1, 10.1038/ncomms11215 Zheng, 2017, Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p, PLoS One, 12, 10.1371/journal.pone.0184746 Zhou, 2021, Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China, Ophthalmology Zhou, 2016, Oncogenic role of microRNA20a in human uveal melanoma, Mol. Med. Rep., 14, 1560, 10.3892/mmr.2016.5433 Zhou, 2016, Oncogenic role of microRNA-20a in human uveal melanoma, Mol. Med. Rep., 14, 1560, 10.3892/mmr.2016.5433 Zhou, 2016, Oncogenic role of microRNA-20a in human uveal melanoma, Mol. Med. Rep., 14, 1560, 10.3892/mmr.2016.5433 Zhou, 2019, Regulation of co-transcriptional pre-mRNA splicing by m6A through the low-complexity protein hnRNPG, Mol. Cell, 76, 70, 10.1016/j.molcel.2019.07.005 Zhou, 2015, Let-7b overexpression leads to increased radiosensitivity of uveal melanoma cells, Melanoma Res., 25, 119, 10.1097/CMR.0000000000000140 Zhu, 2001, DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors, Cancer Res., 61, 1327